Skip to main content

Table 3 Effectiveness of Vaccination against any lung injury

From: COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia

 

Crude VE

VE adjusted for

VE adjusted for age, sex, and

 

(95% CI)

age and sex

history of confirmed COVID-19

  

(95% CI)

(95% CI)

Gam-COVID-Vac (2-dose Sputnik V)

57% (48–64)

64% (56–70)

69% (62–74)

Gam-COVID-Vac (1-dose Sputnik Light)

56% (36–70)

58% (38–71)

58% (37–72)

EpiVacCorona

-82% (-280–13)

-52% (-205–24)

-30% (-165–37)

CoviVac

43% (4–66)

44% (5–67)

49% (11–70)

Other

-22% (-137–37)

-24% (-130–33)

-1% (-89–46)

Any vaccine: partial vaccination

33% (-24–66)

35% (-30–64)

36% (-25–67)